02/01/2026
I keep hearing scaremongering about GLP-1 medications and long-term use—often from people who aren’t familiar with the clinical evidence.
The evidence tells a different story. The GLP-1 class of drugs has been studied for over 20 years, with a safety profile established in millions of patients since the early 2000s.
Mounjaro (Tirzepatide) represents the next generation of this science. While newer, it has been rigorously studied in over 10,000 trial participants over the last 9 years, building directly on that 20-year legacy of safety.
While some questions remain for lifelong use in obesity, the long-term harms of obesity itself are already proven, progressive, and life-limiting.
For many, GLP-1 medications are a vital tool to achieve meaningful, sustainable weight loss—especially when combined with structured exercise and nutrition support.
As a specialist coach, my role is to help clients protect the engine: preserving muscle, strength, and metabolic health with in-home coaching designed to make your progress simple, safe, and sustainable.
📩 Send me a message or book a free consultation to see how the PMA Method can support your journey.
Many thanks,
Peter
🌐 www.pmapersonaltraining.com
